Parapnuemonic Effusion &
Empyema
DR SUHAS TIPLE
DEFINATION….
Any pleural effusion associated with BACTERIAL PNUMONIA,LUNG
ABSCESS OR BRONCHECTASIS IS A PARAPNUMONIC EFFUSION
EMPYEMA is pus in pleural space
Parapnuemonic Effusion &
Empyema
DR SUHAS TIPLE
DEFINATION….
Any pleural effusion associated with BACTERIAL PNUMONIA,LUNG
ABSCESS OR BRONCHECTASIS IS A PARAPNUMONIC EFFUSION.
EMPYEMA is pus in pleural space .
4ee444444444szzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzz
zzz
A
C
C
P
Option for management of pleural fluid
• Observation
• Therapeutic thoracentesis
• Tube thoracostomy
• Intrapleural fibronolytics
• VATS with lysis of adhesion and /or decortication
• Decortication
• Open drainage
Observation
• Its not acceptable option because pleural fluid from patient with
parapnumonic effusion should be sampled as soon as possible ,
Therapeutic thoracentesis
• Its treatment modality for parapneumonic effusion .
• ATS recommended repeated thoracentesis for non tb empyema ,that
were in the early exudative phase .
• In 1968 snider and saleh recommended that pt with empyema could
managed with two therapeutic thoracentesis, but if fluid accumulated
after that time ,tube thoracostomy should be performed.
Tube thoracostomy
• Its for complicated parapneumonic effusion
• Tube size relatively large 28 to 36 F old time
• Now small size <14 F size used
• MULTI- CENTERED INTRAPLEURAL SEPSIS (STREPTOKINASE) TRIAL
(MIST 1) : 2005 yr
• CONCLUSSION : intrapleural administration of stk does not improve
mortality , the rate of surgery , or the length of the hospital stay
among pt with pleural infection.
• Stk 2.5lack iu or saline for 3 days
• Eligible purulent ,grm stain positive ph below 7.2
INTRAPLEURAL FIBRONOLYTICS
• Its for complicated parapnumic effusion
• Mechanism is that destroy the fibrine membrane and facilitate
drainage of pleural fluid.
Intrapleural fibrinolytics
• MIST 2 TRIAL (2011)
• CONCLUSSION :
1. intrapleural t-PA-Dnase therapy improved fluid drainage in
patient with pleural infection and reduced the frequency of surgical
referral and duration of the hospital stay .
2. Treatment with Dnase (14.7%)alone t-PA ALONE (17.2%)was
ineffective as compared to administration of combination t-PA and
Dnase (29.5%)significantly greater reduction in pleural opacity .
VATS WITH LYSIS OF ADHESSION AND /OR
DECORTICATION
• Its for incompletely drained of parpnuemonic effusion
• Medical thoracoscopy is occasionly used in this situation. VATS
usually preferred because if lung cannot be expanded and it can be
converted to full thoracotomy
• DECORTICATION : All fibrous tissue is removed from visceral and
parietal pleura and all pus is evacuated from pleural space .
• decortication allows underlying lung to expand and eliminate the
pleural sepsis.
THANK YOU……!!!
Empyema

Empyema

  • 1.
  • 2.
    DEFINATION…. Any pleural effusionassociated with BACTERIAL PNUMONIA,LUNG ABSCESS OR BRONCHECTASIS IS A PARAPNUMONIC EFFUSION EMPYEMA is pus in pleural space
  • 6.
  • 7.
    DEFINATION…. Any pleural effusionassociated with BACTERIAL PNUMONIA,LUNG ABSCESS OR BRONCHECTASIS IS A PARAPNUMONIC EFFUSION. EMPYEMA is pus in pleural space .
  • 15.
  • 16.
  • 29.
    Option for managementof pleural fluid • Observation • Therapeutic thoracentesis • Tube thoracostomy • Intrapleural fibronolytics • VATS with lysis of adhesion and /or decortication • Decortication • Open drainage
  • 30.
    Observation • Its notacceptable option because pleural fluid from patient with parapnumonic effusion should be sampled as soon as possible ,
  • 31.
    Therapeutic thoracentesis • Itstreatment modality for parapneumonic effusion . • ATS recommended repeated thoracentesis for non tb empyema ,that were in the early exudative phase . • In 1968 snider and saleh recommended that pt with empyema could managed with two therapeutic thoracentesis, but if fluid accumulated after that time ,tube thoracostomy should be performed.
  • 35.
    Tube thoracostomy • Itsfor complicated parapneumonic effusion • Tube size relatively large 28 to 36 F old time • Now small size <14 F size used • MULTI- CENTERED INTRAPLEURAL SEPSIS (STREPTOKINASE) TRIAL (MIST 1) : 2005 yr • CONCLUSSION : intrapleural administration of stk does not improve mortality , the rate of surgery , or the length of the hospital stay among pt with pleural infection.
  • 36.
    • Stk 2.5lackiu or saline for 3 days • Eligible purulent ,grm stain positive ph below 7.2
  • 37.
    INTRAPLEURAL FIBRONOLYTICS • Itsfor complicated parapnumic effusion • Mechanism is that destroy the fibrine membrane and facilitate drainage of pleural fluid.
  • 38.
    Intrapleural fibrinolytics • MIST2 TRIAL (2011) • CONCLUSSION : 1. intrapleural t-PA-Dnase therapy improved fluid drainage in patient with pleural infection and reduced the frequency of surgical referral and duration of the hospital stay . 2. Treatment with Dnase (14.7%)alone t-PA ALONE (17.2%)was ineffective as compared to administration of combination t-PA and Dnase (29.5%)significantly greater reduction in pleural opacity .
  • 41.
    VATS WITH LYSISOF ADHESSION AND /OR DECORTICATION • Its for incompletely drained of parpnuemonic effusion • Medical thoracoscopy is occasionly used in this situation. VATS usually preferred because if lung cannot be expanded and it can be converted to full thoracotomy • DECORTICATION : All fibrous tissue is removed from visceral and parietal pleura and all pus is evacuated from pleural space . • decortication allows underlying lung to expand and eliminate the pleural sepsis.
  • 43.